Niki Biosolutions (NIKI) closed at $1.83 on October 23, 2026, down 1.6% from the previous close, on volume of 4,791 shares (30-day average 30,832).
Data as of October 23, 2026.
Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research
Globe Newswire (Fri, 23-Oct 8:00 AM ET)
Globe Newswire (Fri, 16-Oct 8:00 AM ET)
Globe Newswire (Wed, 14-Oct 8:00 AM ET)
Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference
Globe Newswire (Fri, 25-Sep 8:30 AM ET)
Globe Newswire (Mon, 14-Sep 8:30 AM ET)
Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Globe Newswire (Tue, 8-Sep 8:00 AM ET)
Niki BioSolutions Expands Precision Medicine Footprint with APOE Genotyping Partnership
Market Chameleon (Thu, 23-Jul 4:38 AM ET)
Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies.
Niki Biosolutions trades on the NASDAQ stock market under the symbol NIKI.
As of October 23, 2026, NIKI stock price declined to $1.83 with 4,791 million shares trading.
NIKI has a beta of 6.52, meaning it tends to be more sensitive to market movements. NIKI has a correlation of 0.21 to the broad based SPY ETF.
NIKI has a market cap of $1.49 million. This is considered a Sub-Micro Cap stock.
NIKI support price is $1.65 and resistance is $2.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NIKI shares will trade within this expected range on the day.
